Third Edition of Cancer Atlas highlights patterns and inequities in cancer burden

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Cancer Society, Union for International Cancer Control and International Agency for Research on Cancer have published The Cancer Atlas, 3rd edition, an overview of cancer around the globe.

The document, released at the World Cancer Leaders’ Summit in Nur-Sultan, Kazakhstan, can be downloaded here. In addition to the printed report, the information is included on this interactive website.

The atlas highlights distinct patterns and inequities in the cancer burden around the world; outlines the risk factors that are driving cancer patterns; and details the prospects for cancer prevention and control. The theme of the current edition is “Access Creates Progress.”

Cancer is the leading or second-leading cause of premature death (under age 70) in 91 countries. Based on expected population growth and aging alone, the number of global cancer cases is expected to increase by 60% in 2040. More widespread distribution of lifestyle factors such as smoking, unhealthy diet, and physical inactivity are likely to make that number considerably larger.

Table of Contents

YOU MAY BE INTERESTED IN

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login